Eric Gauthier

8PUBLICATIONS
81CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsChemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 25, 2025
Circulating Tumor Cell Dynamics after CDK4/6 Inhibitor for Hormone Receptor-Positive Metastatic Breast Cancer: A Biomarker Analysis from the PACE Phase II Study.

Lorenzo Gerratana, Carolina Reduzzi, Yue Ren

|Aug 18, 2025
Circulating Tumor DNA Genotyping of Intrinsic and Acquired Gene Alterations in Patients With Advanced Breast Cancer Receiving Palbociclib: Biomarker Results From POLARIS Study.

Debu Tripathy, Joanne L Blum, Hong Zhang

|Oct 30, 2024
Real-world effectiveness of palbociclib plus endocrine therapy in HR+/HER2- advanced breast cancer: final results from the POLARIS trial.

Debu Tripathy, Joanne L Blum, Meghan S Karuturi

|Jul 01, 2024
Effect of cross-platform gene-expression, computational methods on breast cancer subtyping in PALOMA-2 and PALLET studies.

Maggie Chon U Cheang, Mothaffar Rimawi, Stephen Johnston

|Mar 21, 2024
PACE: A Randomized Phase II Study of Fulvestrant, Palbociclib, and Avelumab After Progression on Cyclin-Dependent Kinase 4/6 Inhibitor and Aromatase Inhibitor for Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor-Negative Metastatic Breast Cancer.

Erica L Mayer, Yue Ren, Nikhil Wagle

|Jan 22, 2024
Overall Survival With Palbociclib Plus Letrozole in Advanced Breast Cancer.

Dennis J Slamon, Véronique Diéras, Hope S Rugo

Pageof 2

Frequent Collaborators

3 joint publications

Hope S Rugo

3 joint publications

Kathy Miller

3 joint publications

Erica L Mayer

3 joint publications

Angela DeMichele